Alkermes (ALKS) Gross Margin (2010 - 2026)
Alkermes (ALKS) reported Gross Margin of 293.83% for Q1 2026, down 35372.0% year-over-year from N/an in Q1 2025, and down 527.55% quarter-over-quarter from 68.72% in Q4 2025.
Alkermes (ALKS) Gross Margin (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Gross Margin data on file, last reported at 293.83% in Q1 2026.
- Gross Margin for Q1 2026 came in at 293.83%, down 35372.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 63.53% (down 1345.0% YoY), and the FY2025 annual result was 67.48%, down 1677.0% from the prior year.
- Gross Margin eased to 293.83% in Q1 2026 per ALKS's latest filing, from 68.72% in the prior quarter.
- Over five years, Gross Margin peaked at 89.76% in Q2 2023 and troughed at 1723.75% in Q2 2022.
- A 5-year average of 141.67% and a median of 79.78% in 2023 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2023: Gross Margin plunged 180626 bps in 2022, then surged 181351 bps in 2023.
- A 5-year view of Gross Margin shows it stood at 82.3% in 2022, then dropped by 1 bps to 81.42% in 2023, then increased by 5 bps to 85.55% in 2024, then decreased by 20 bps to 68.72% in 2025, then tumbled by 528 bps to 293.83% in 2026.
- Business Quant data shows ALKS's Gross Margin at 293.83% in Q1 2026, 68.72% in Q4 2025, and 70.67% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -293.83% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 61.20% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 65.25% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 91.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -293.83% |
| Dec 31, 2025 | 68.72% |
| Sep 30, 2025 | 70.67% |
| Jun 30, 2025 | 87.34% |
| Mar 31, 2025 | 59.89% |
| Dec 31, 2024 | 85.55% |
| Sep 30, 2024 | 73.01% |
| Jun 30, 2024 | 84.60% |
| Mar 31, 2024 | 64.15% |
| Dec 31, 2023 | 81.42% |
| Sep 30, 2023 | 83.86% |
| Jun 30, 2023 | 89.76% |
| Mar 31, 2023 | 79.78% |
| Dec 31, 2022 | 82.30% |
| Sep 30, 2022 | -1,482.03% |
| Jun 30, 2022 | -1,723.75% |
| Mar 31, 2022 | 80.20% |
| Dec 31, 2021 | 83.47% |
| Sep 30, 2021 | 83.15% |
| Jun 30, 2021 | 82.51% |